A: Semaglutide is a single GLP-1 receptor agonist, while Tirzepatide is a dual GLP-1/GIP receptor agonist
And Lillys oral GLP-1, orforglipron, is expected to launch soon, signaling broader class expansion
Semaglutide reduces appetite, but what you eat still determines your weight loss speed and whether you maintain results long-term
My Doctor Is Impressed My PCP was skeptical at first, but after seeing my labs improve across the board he's fully on board
PlexusDx helps you navigate GLP-1 treatment with personalized dosing and genetic insights to minimize disruptions to your daily life
Theoretical concerns based on mechanism include phosphate dysregulation from chronic renal phosphate wasting, potential antibody formation against the peptide sequence with repeated dosing, and unknown reproductive or developmental effects